1. Home
  2. CRWS vs ALXO Comparison

CRWS vs ALXO Comparison

Compare CRWS & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRWS
  • ALXO
  • Stock Information
  • Founded
  • CRWS 1957
  • ALXO 2015
  • Country
  • CRWS United States
  • ALXO United States
  • Employees
  • CRWS N/A
  • ALXO N/A
  • Industry
  • CRWS Textiles
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRWS Consumer Discretionary
  • ALXO Health Care
  • Exchange
  • CRWS Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • CRWS 34.0M
  • ALXO 28.3M
  • IPO Year
  • CRWS N/A
  • ALXO 2020
  • Fundamental
  • Price
  • CRWS $3.20
  • ALXO $0.48
  • Analyst Decision
  • CRWS
  • ALXO Strong Buy
  • Analyst Count
  • CRWS 0
  • ALXO 6
  • Target Price
  • CRWS N/A
  • ALXO $3.54
  • AVG Volume (30 Days)
  • CRWS 19.1K
  • ALXO 519.4K
  • Earning Date
  • CRWS 06-27-2025
  • ALXO 05-08-2025
  • Dividend Yield
  • CRWS 9.89%
  • ALXO N/A
  • EPS Growth
  • CRWS N/A
  • ALXO N/A
  • EPS
  • CRWS 0.24
  • ALXO N/A
  • Revenue
  • CRWS $86,602,000.00
  • ALXO N/A
  • Revenue This Year
  • CRWS N/A
  • ALXO N/A
  • Revenue Next Year
  • CRWS N/A
  • ALXO N/A
  • P/E Ratio
  • CRWS $13.40
  • ALXO N/A
  • Revenue Growth
  • CRWS N/A
  • ALXO N/A
  • 52 Week Low
  • CRWS $2.80
  • ALXO $0.44
  • 52 Week High
  • CRWS $5.35
  • ALXO $17.50
  • Technical
  • Relative Strength Index (RSI)
  • CRWS 54.95
  • ALXO 40.94
  • Support Level
  • CRWS $2.95
  • ALXO $0.41
  • Resistance Level
  • CRWS $3.15
  • ALXO $0.55
  • Average True Range (ATR)
  • CRWS 0.11
  • ALXO 0.05
  • MACD
  • CRWS 0.06
  • ALXO 0.00
  • Stochastic Oscillator
  • CRWS 78.79
  • ALXO 31.14

About CRWS Crown Crafts Inc

Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: